Immediate Impact
1 from Science/Nature 62 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Works of Chikara Ogawa being referenced
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
2019
Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chikara Ogawa | 669 | 353 | 136 | 158 | 48 | 942 | |
| Sang Jun Suh | 630 | 577 | 100 | 192 | 47 | 1.1k | |
| Xin Zhang | 586 | 330 | 99 | 138 | 59 | 905 | |
| Kinya Okamoto | 430 | 420 | 97 | 280 | 46 | 1.0k | |
| Michela Emma Burlone | 661 | 580 | 92 | 81 | 41 | 1.0k | |
| Anna Pecorelli | 649 | 655 | 105 | 114 | 43 | 1.1k | |
| Khaled Zalata | 353 | 376 | 80 | 126 | 60 | 908 | |
| Hirokazu Kawai | 353 | 299 | 100 | 196 | 63 | 962 | |
| Sun Young Yim | 459 | 441 | 93 | 217 | 73 | 929 | |
| Sumio Saito | 491 | 392 | 236 | 124 | 65 | 1.1k | |
| Kenneth M. Klein | 276 | 216 | 61 | 158 | 41 | 851 |
All Works
Login with ORCID to disown or claim papers
Loading papers...